Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease
出版年份 2019 全文链接
标题
Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease
作者
关键词
Parkinson’s disease, Cognition, CB<sub>1</sub>R, PET, Behavior, Dementia
出版物
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-24
DOI
10.1007/s00259-019-04445-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18 F-FDG PET imaging
- (2018) Lei Wu et al. HUMAN BRAIN MAPPING
- Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease
- (2018) Seok Jong Chung et al. PARKINSONISM & RELATED DISORDERS
- Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson’s Disease
- (2018) Tino Prell Frontiers in Neurology
- Supraoptimal Cytokinin Content Inhibits Rice Seminal Root Growth by Reducing Root Meristem Size and Cell Length via Increased Ethylene Content
- (2018) Xiao Zou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- Impulse control disorder and response-inhibition alterations in Parkinson’s disease. A rare case of totally absent functionality of the medial-prefrontal cortex and review of literature
- (2017) Sara Palermo et al. Journal of Advanced Research
- Targeting the Endocannabinoid System in Psychiatric Illness
- (2016) Martin A. Katzman et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study
- (2016) M J Firbank et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A cannabinoid link between mitochondria and memory
- (2016) Etienne Hebert-Chatelain et al. NATURE
- Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
- (2016) Stephen N. Gomperts et al. JAMA Neurology
- Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
- (2016) Nora D. Volkow et al. JAMA Psychiatry
- Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson’s Disease
- (2016) Yilin Tang et al. PLoS One
- The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions
- (2015) Mechelle M. Lewis et al. JOURNAL OF NEUROLOGY
- Pharmacological Treatment of Parkinson Disease
- (2014) Barbara S. Connolly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
- (2014) Anthony H V Schapira et al. LANCET
- Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis Use Interact on Prefrontal Connectivity and Related Working Memory Behavior
- (2014) Marco Colizzi et al. NEUROPSYCHOPHARMACOLOGY
- WIN55,212-2 impairs non-associative recognition and spatial memory in rats via CB1 receptor stimulation
- (2014) A. Galanopoulos et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Performance in working memory and attentional control is associated with the rs2180619 SNP in theCNR1gene
- (2013) A. E. Ruiz-Contreras et al. GENES BRAIN AND BEHAVIOR
- CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations
- (2013) Balapal S. Basavarajappa et al. HIPPOCAMPUS
- Cognitive Change in Newly-Diagnosed Patients with Parkinson's Disease: A 5-Year Follow-up Study
- (2013) Mark Broeders et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Working memory performance in young adults is associated to the AATn polymorphism of the CNR1 gene
- (2012) Alejandra E. Ruiz-Contreras et al. BEHAVIOURAL BRAIN RESEARCH
- Endocannabinoid Signaling and Synaptic Function
- (2012) Pablo E. Castillo et al. NEURON
- Cognitive Impairment and Dementia in Parkinson’s Disease: Clinical Features, Diagnosis, and Management
- (2012) Joana Meireles et al. Frontiers in Neurology
- Endocannabinoid system dysfunction in mood and related disorders
- (2011) C. H. Ashton et al. ACTA PSYCHIATRICA SCANDINAVICA
- Cannabinoid Transmission in the Basolateral Amygdala Modulates Fear Memory Formation via Functional Inputs to the Prelimbic Cortex
- (2011) H. Tan et al. JOURNAL OF NEUROSCIENCE
- MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI
- (2011) Irene Litvan et al. MOVEMENT DISORDERS
- Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
- (2011) Koen Van Laere et al. NEUROBIOLOGY OF AGING
- Effects of endocannabinoid system modulation on cognitive and emotional behavior
- (2011) Claudio Zanettini Frontiers in Behavioral Neuroscience
- Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
- (2010) P. A. Kempster et al. BRAIN
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Are CB1 receptor antagonists nootropic or cognitive impairing agents?
- (2009) Stephen A. Varvel et al. DRUG DEVELOPMENT RESEARCH
- Distinct brain networks in recognition memory share a defined region in the precuneus
- (2009) Denise Dörfel et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
- (2009) Sandra Marina Sanabria-Bohórquez et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cognitive decline in Parkinson’s disease: A prospective longitudinal study
- (2009) DINO MUSLIMOVIĆ et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats
- (2008) Miriam Schneider et al. ADDICTION BIOLOGY
- Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson model
- (2008) Sanneke A.M. van Vliet et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Targeting the endocannabinoid system: to enhance or reduce?
- (2008) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET
- (2007) Koen Van Laere et al. NEUROIMAGE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now